Mayne Pharma Group Mergers and Acquisitions Summary

Life ScienceCompany

Mayne Pharma Group has acquired 4 companies. It has also divested 2 assets.

Mayne Pharma Group’s largest acquisition to date was in 2012, when it acquired Metrics for $120M. It’s largest disclosed sale occurred in 2022, when it sold Metrics Contract Services to Catalent for $475M. Mayne Pharma Group has acquired in 3 different US states, and 2 countries. The Company’s most targeted sectors include life science (100%).

Join Mergr and gain access to Mayne Pharma Group’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity6
    • M&A Buy Activity4
    • M&A Sell Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 3

Mayne Pharma Group Ltd.

1528 Main North Road,
Salisbury South, 5106
Australia,
61 8 8209 2666
www.maynepharma.com

Mayne Pharma Group Ltd. is a specialty pharmaceutical company that develops and manufactures branded and generic products, which it distributes globally, either directly or through distribution partners and also provides contract development and manufacturing services.


M&A Summary

Buy vs Sell

Year ≤ '18 '19 '20 '21 '22 '23 T
Buy (0.0/yr) # 4 - - - - - 4
vol $120M $120M
Sell (0.2/yr) # 1 - - - 1 - 2
vol $475M $475M
  6

Most Recent M&A

Company Date Value Type
Metrics Contract Services 2022-08-09 475M USD Divestiture
Greenville, North Carolina · www.metricscontractservices.com
Mayne Pharma Group Ltd.- 15 Mayne Pharma Products 2016-12-06 - Divestiture
Salisbury South, Australia
Actavis Doryx Brand and Related Assets 2015-02-24 - Divestiture
, United States
Libertas Pharma Inc. 2013-07-02 - Add-on Acquisition
Lawrenceville, Georgia · www.libertaspharma.com
Metrics, Inc. 2012-10-05 120M USD Add-on Acquisition
Greenville, North Carolina · www.metricsinc.com
FH Faulding & Co., Ltd. 2009-10-30 - Add-on Acquisition
Salisbury South, Australia
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 4 (100%) 120M (100%) 1 (50%) 475M (100%)
Medical Products - - 1 (50%) -
Total 4 $120M 2 $475M

By Geo

State/Country Buy Value Sell Value
United States 3 120M 1 475M
  North Carolina 1 120M 1 475M
  Georgia 1 - - -
Australia 1 - 1 -
Domestic 1 (25%) - 1 (50%) -
Cross-border 3 (75%) 120M (100%) 1 (50%) 475M (100%)
Total 4 $120M 2 $475M

Deal Values

buy # Total
$100M to $1B 1 $120M
TOTAL $120M
Largest Metrics, Inc.
$120M (2012-10-05)
sell # Total
$100M to $1B 1 $475M
TOTAL $475M
Largest Metrics Contract Services
$475M (2022-08-09)

M&A Connections

Deals
Acquired from
Strategic(s)
25%
1 (25%)
Divested to
Strategic(s)
100%
2 (100%)

 Subscribe to unlock this and 194,997
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 186K M&A Transactions
  • 191K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.5K M&A Advisors
    (Investment Banks and Law Firms)
  • 72K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Mayne Pharma Group Ltd.

Life Science Companies , Australia Companies